Clinical Trial: A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasis

U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06906900) titled 'A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasis' on March 26.

Brief Summary: This clinical research study is to learn about the safety of the NovoTTF-200M and Novo TTF-200A Systems, when used either alone or in combination with standard therapy, in patients with tumors that did not respond to treatment.

Study Start Date: Sept. 01, 2025

Study Type: INTERVENTIONAL

Condition: Spinal Metastasis

Intervention: DEVICE: TTF-200M and TTF-200A systems

Participants will receive one cycle of therapy with NovoTTF-200M or NovoTTF-200A is 3 months (+/- 1 month)

Recruitment Sta...